Singapore medTech company Advent Access raises S$2.6 Million in Pre-Series A financing

Advent Access (Advent), one of Singapore’s most innovative medtech companies, today announced that it has closed a pre-Series A financing round, having raised S$2.6 million in investments and collaboration to advance the development and commercialization of its patented av-GuardianTM technology for vascular access in dialysis patients. The financing was led by Accuron MedTech (Accuron), the largest medical device company in Southeast Asia.

The investment was made through the Med Tech Alliance, an accelerator appointed by Singapore’s SPRING SEEDS Capital to facilitate the growth of start-ups in the local medtech industry.

Peh Ruey Feng, Founder and Chief Executive Officer of Advent Access, said: "We are excited to have Temasek-backed Accuron MedTech onboard.  Abel and the Accuron team bring deep experience in growing technologies from Asia, breadth in accessing international markets and financial depth in nurturing startups that will set us apart regionally and internationally. Advent Access is now well equipped to accelerate the development of av-GuardianTM and tackle some of the most pressing needs in end-stage renal disease. Working closely with Accuron, we look forward to unlocking the future of independent dialysis."

Vascular access is essential for patients undergoing dialysis, providing a reliable site where the bloodstream can be easily accessed for each procedure. However, placing dialysis needles is often the most stressful part of the treatment. If the needles are not well placed, complications can arise and dialysis is inadequately performed.  It is the most common cause of hospitalization in patients suffering end-stage renal disease, directly impacting the cost efficiency of the treatment and the quality of life of patients.

Advent Access has developed the av-GuardianTM, an award-winning device-guided needling platform that engineers a high-quality tissue track to enable reliable and less-painful vascular access to the arteriovenous fistula (AV fistula) commonly used by dialysis patients.